FdaApplication
NDA 022535
Identifiers
- fda_app_no: NDA022535
Properties
| Property | Value |
|---|---|
| applicant_name | LEGACY PHARMA INC SEZC |
| application_type | NDA |
| approval_date | 2014-10-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESBRIET | PIRFENIDONE | 267MG | CAPSULE;ORAL |
1 product